Home / Generics

Generics

News

Price of leukaemia drug in Japan halved posted 25/05/2018

Japanese drugmaker Ohara Pharmaceutical has reduced the price of its leukaemia generic imatinib to about half the price of th...

Hikma launches HIV generic ritonavir in the US posted 18/05/2018

Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) announced on 20 March 2018 that its wholly owned US subsidiary West-Ward...

Alvogen receives European approval for generic lenalidomide posted 11/05/2018

US generics company Alvogen announced on 24 April 2018 that it had successfully concluded multiple registration procedures fo...

Teva launches ulcerative colitis generic in the US posted 27/04/2018

Israeli generics giant Teva Pharmaceutical Industries (Teva) announced on 26 March 2018 that it had launched generic mesalami...

Australia’s Mayne Pharma launches generic antibiotic in US posted 13/04/2018

Australia-based Mayne Pharma announced on 15 March 2018 that it had launched a generic version of doxycycline monohydrate imm...

 

Research

Encouraging generics could cause high prices posted 25/05/2018

A provision introduced in October 2017 awards eligible drugmakers 180 days of exclusivity to market a generic version of one...

Trends in use of Lipitor after introduction of generic atorvastatin posted 04/05/2018

Big savings can be made after the introduction of generics, especially when it comes to high volume categories, such as stati...

Switchback rates between generic and brand-name drugs posted 02/05/2018

A study carried out by researchers from Harvard Medical School found a lower rate of switchback when patients were switched t...

Portugal increases use of generics for treatment of cardiovascular diseases posted 06/04/2018

In Portugal, the use of medicines for cardiovascular system increased nearly two-fold between 2000 and 2010. As such, over a...

Pharmaceuticals and products liability litigation posted 06/04/2018

In 2016, healthcare spending represented 17.9% of the economy of the US, a slight increase from 2015. By 2016, the average co...

 

General

EMA collaboration on oversight of API makers posted 11/05/2018

The European Medicines Agency (EMA) announced on 12 April 2018 that it had published the International API inspection program...

Generics companies defend against illegal ‘pay-for-delay’ charges posted 20/04/2018

In March 2018, pharmaceutical companies in the US and Europe have had to defend themselves against antitrust charges. Illegal...

NGO urges HIV drug patent application to be denied in Argentina posted 06/04/2018

In March 2018, Argentine NGO, the Fundación Grupo Efecto Positivo (FGEP), requested that the country’s National Institute of...

US government tries to address the increasing cost of drugs posted 08/03/2018

A report released by the Council of Economic Advisers (CEA), an executive office of the President of the US, in February 2018...

Canada’s generics industry to cut prices by up to 40% posted 23/02/2018

The pan-Canadian Pharmaceutical Alliance (pCPA) announced on 29 January 2018 that together with participating federal, p...